rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

John M. Keane

Director

Company insider

Files Form 4 as: Director, SIGA Technologies; Director, United States Antimony; Director, IronNet; Director, General Dynamics; Director, MetLife; Director, Scientific Games; Director, M & F Worldwide; Director, Cyalume Technologies Holdings.

In numbers

Trades disclosed
183
Buys
15
Sells
10
Bought
$116K
Sold
$3.9M
Companies
8
Companies where not an officer
8
First trade
3 Jan 2006
Last trade
9 Jun 2026
Last filed
10 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
SIGA SIGA TechnologiesDirector · Pharmaceuticals · last 9 Jun 20260 buys · 0 sells
UAMY United States AntimonyDirector · Steel & Metals Processing · last 15 Jan 20260 buys · 0 sells
IronNetDirector · last 14 Jul 20221 buy · 0 sells
GD General DynamicsDirector · Aerospace & Defense · last 16 Mar 201814 buys · 9 sells
MET MetLifeDirector · Insurance · last 13 Mar 20150 buys · 1 sell
Scientific GamesDirector · last 23 Apr 20140 buys · 0 sells
M & F WorldwideDirector · last 21 Dec 20110 buys · 0 sells
Cyalume Technologies HoldingsDirector · last 4 Feb 20100 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
9 Jun 2026filed 10 Jun 2026SIGA SIGA TechnologiesPharmaceuticalsSEC FORM 4 Code M—24,116filing
9 Jun 2026filed 10 Jun 2026SIGA SIGA TechnologiesPharmaceuticalsSEC FORM 4 Code D$32K7,235 at $4.39filing
9 Jun 2026filed 10 Jun 2026SIGA SIGA Technologiesoption or derivative · PharmaceuticalsSEC FORM 4 Code M—24,116 at $0.00filing
9 Jun 2026filed 10 Jun 2026SIGA SIGA Technologiesoption or derivative · PharmaceuticalsSEC FORM 4 Code M—24,116 at $0.00filing
9 Jun 2026filed 10 Jun 2026SIGA SIGA Technologiesoption or derivative · PharmaceuticalsSEC FORM 4 Code A—34,169 at $0.00filing
9 Jun 2026filed 10 Jun 2026SIGA SIGA Technologiesoption or derivative · PharmaceuticalsSEC FORM 4 Code A—34,169 at $0.00filing
9 Jun 2026filed 10 Jun 2026SIGA SIGA TechnologiesPharmaceuticalsSEC FORM 4 Code M—24,116filing
9 Jun 2026filed 10 Jun 2026SIGA SIGA TechnologiesPharmaceuticalsSEC FORM 4 Code D$32K7,235 at $4.39filing
15 Jan 2026filed 27 Jan 2026UAMY United States Antimonyoption or derivative · Steel & Metals ProcessingSEC FORM 4 Code A—7,464filing
15 Jan 2026filed 27 Jan 2026UAMY United States Antimonyoption or derivative · Steel & Metals ProcessingSEC FORM 4 Code A—4,597filing
15 Jan 2026filed 27 Jan 2026UAMY United States Antimonyoption or derivative · Steel & Metals ProcessingSEC FORM 4 Code A—7,464filing
15 Jan 2026filed 27 Jan 2026UAMY United States Antimonyoption or derivative · Steel & Metals ProcessingSEC FORM 4 Code A—4,597filing
10 Jun 2025filed 11 Jun 2025SIGA SIGA Technologiesoption or derivative · PharmaceuticalsSEC FORM 4 Code A—24,116 at $0.00filing
17 Mar 2025filed 19 Mar 2025SIGA SIGA Technologiesoption or derivative · PharmaceuticalsSEC FORM 4 Code A—25,000 at $0.00filing
14 Jul 2022filed 14 Jul 2022IronNetSEC FORM 4 Code A—76,174 at $0.00filing
3 Jan 2022filed 4 Jan 2022IronNetSEC FORM 4 Bought$106K25,000 at $4.24filing
7 Dec 2021filed 9 Dec 2021IronNetSEC FORM 4 Code A—24,000 at $0.00filing
10 Sep 2021filed 14 Sep 2021IronNetSEC FORM 4 Code A—5,045filing
26 Aug 2021filed 30 Aug 2021IronNetSEC FORM 4 Code A—358,206filing
16 Mar 2018filed 19 Mar 2018GD General DynamicsAerospace & DefenseSEC FORM 4 Code A$21K95 at $222.56filing

Sectors

Industrials23
Financials1
Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Lloyd BardswichDir, EVP & Chief Mining Eng · Dir, EVP & Chief Mining Eng at United States Antimony, filing Form 4 there in the last year
Joseph A. CarrabbaDirector · Director at United States Antimony, filing Form 4 there in the last year
Blaise A. AguirreDirector · Director at United States Antimony, filing Form 4 there in the last year
Gary C. EvansChairman & CEO · Chairman & CEO at United States Antimony, filing Form 4 there in the last year
Jon R. MarinelliDirector · Director at United States Antimony, filing Form 4 there in the last year
Robert K. SteelDirector · Also traded GD in the last 90 days
Peter A. WallDirector · Also traded GD in the last 90 days
Christopher J. BradyVice President · Also traded GD in the last 90 days